Atos Valuation

Is 0DNH undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0DNH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 0DNH's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 0DNH's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0DNH?

Key metric: As 0DNH is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0DNH. This is calculated by dividing 0DNH's market cap by their current revenue.
What is 0DNH's PS Ratio?
PS Ratio0.003x
Sales€10.14b
Market Cap€34.48m

Price to Sales Ratio vs Peers

How does 0DNH's PS Ratio compare to its peers?

The above table shows the PS ratio for 0DNH vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
ING Ingenta
1.1xn/aUK£11.0m
TPX TPXimpact Holdings
0.4x7.0%UK£29.7m
TRD Triad Group
3xn/aUK£54.2m
MTEC Made Tech Group
0.9x1.8%UK£33.1m
0DNH Atos
0.003x-1.6%€17.3m

Price-To-Sales vs Peers: 0DNH is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (1.3x).


Price to Sales Ratio vs Industry

How does 0DNH's PS Ratio compare vs other companies in the GB IT Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.0.9x7.2%
0DNH Atos
0.003x-1.6%US$18.17m
NVIQ Noventiq Holdings
0.1xn/aUS$228.10m
CLCO CloudCoCo Group
0.06xn/aUS$1.99m
No more companies available in this PS range
0DNH 0.0xIndustry Avg. 0.9xNo. of Companies6PS01.22.43.64.86+
3 CompaniesEstimated GrowthMarket Cap
Industry Avg.0.9x13.8%
0DNH Atos
0.003x121.4%US$18.17m
No more companies

Price-To-Sales vs Industry: 0DNH is good value based on its Price-To-Sales Ratio (0x) compared to the European IT industry average (0.9x).


Price to Sales Ratio vs Fair Ratio

What is 0DNH's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0DNH PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.003x
Fair PS Ratio0.9x

Price-To-Sales vs Fair Ratio: 0DNH is good value based on its Price-To-Sales Ratio (0x) compared to the estimated Fair Price-To-Sales Ratio (0.7x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0DNH forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€0.31
€0.38
+20.9%
196.0%€2.20€0.005n/a7
Nov ’25€0.68
€0.40
-40.7%
184.1%€2.20€0.005n/a7
Oct ’25€0.70
€0.40
-43.1%
184.1%€2.20€0.0045n/a7
Sep ’25€0.81
€0.40
-50.7%
184.1%€2.20€0.0045n/a7
Aug ’25€0.95
€0.54
-43.0%
136.5%€2.20€0.01n/a7
Jul ’25€0.98
€0.54
-44.8%
137.0%€2.20€0.01n/a7
Jun ’25€1.67
€1.49
-11.1%
103.5%€4.70€0.15n/a7
May ’25€2.13
€2.04
-4.2%
80.9%€4.70€0.15n/a7
Apr ’25€1.89
€3.34
+77.1%
56.1%€6.00€0.20n/a7
Mar ’25€2.36
€5.24
+121.9%
41.5%€10.00€2.50n/a7
Feb ’25€3.88
€5.61
+44.6%
31.8%€10.00€4.00n/a8
Jan ’25€7.13
€6.78
-5.0%
30.0%€10.00€4.70n/a8
Dec ’24€5.98
€6.65
+11.2%
31.7%€10.00€4.70n/a8
Nov ’24€6.47
€6.90
+6.7%
29.2%€10.00€4.70€0.688
Oct ’24€6.66
€9.22
+38.4%
19.1%€13.00€7.00€0.709
Sep ’24€7.68
€10.29
+34.0%
19.6%€14.00€7.00€0.819
Aug ’24€10.01
€11.71
+17.0%
14.9%€14.50€8.60€0.9510
Jul ’24€13.15
€13.02
-1.0%
18.4%€18.50€10.00€0.9811
Jun ’24€13.95
€12.65
-9.4%
19.3%€18.50€10.00€1.6711
May ’24€12.08
€12.65
+4.7%
19.3%€18.50€10.00€2.1311
Apr ’24€11.33
€13.02
+14.9%
24.2%€21.00€10.00€1.8911
Mar ’24€14.38
€10.89
-24.3%
20.2%€15.00€8.00€2.3612
Feb ’24€12.16
€10.63
-12.5%
20.3%€15.00€8.00€3.8812
Jan ’24€9.07
€10.25
+13.0%
19.6%€15.00€8.00€7.1312
Dec ’23€10.36
€10.17
-1.9%
20.2%€15.00€7.90€5.9812
Nov ’23€9.93
€10.06
+1.3%
19.6%€15.00€7.90€6.4712

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies